Home › Funds › Hirtle & Co., LLC › CATH
Hirtle & Co., LLC position in CATH
GLOBAL X FDS
Hirtle & Co., LLC reported holding 30,257 shares of CATH (GLOBAL X FDS) in its Q2 2026 13F filing — a position valued at US$2.7M, representing 0.09% of its reported portfolio and ranking #43 among its reported holdings. Hirtle & Co., LLC has disclosed CATH holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Hirtle & Co., LLC's CATH position evolved
Hirtle & Co., LLC first disclosed a stake in CATH in Q3 2023 at 314,648 shares (US$16.5M). Across 12 filings, Hirtle & Co., LLC increased the stake 0 time(s), trimmed it 7 time(s) and left it unchanged 4 time(s). The most recent filing (Q2 2026) shows 30,257 shares valued at US$2.7M. Notable position changes include a 64% trim in Q1 2024 (shares rose 3% over the following quarter), a 41% trim in Q3 2025 (shares rose 1% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 314.65K | $16.46M | New |
| Q4 2023 | 282.37K | $16.37M | Reduce |
| Q1 2024 | 102.03K | $6.49M | Reduce |
| Q2 2024 | 92.38K | $6.04M | Reduce |
| Q3 2024 | 80.09K | $5.56M | Reduce |
| Q4 2024 | 80.38K | $5.69M | Hold |
| Q1 2025 | 80.38K | $5.43M | Hold |
| Q2 2025 | 68.69K | $5.18M | Reduce |
| Q3 2025 | 40.26K | $3.26M | Reduce |
| Q4 2025 | 40.26K | $3.31M | Hold |
| Q1 2026 | 30.26K | $2.36M | Reduce |
| Q2 2026 | 30.26K | $2.68M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About CATH and 13F data
CATH (GLOBAL X FDS) is a company whose sector is not yet classified in our data. 33 other funds we track also report a position in CATH — the largest reported positions include Fund Evaluation Group, LLC (US$86.4M), CENTRAL TRUST Co (US$47.1M), BCM ADVISORS, LLC (US$20.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding CATH
- Fund Evaluation Group, LLC 976.48K sh · $86.42M · Q2 2026
- CENTRAL TRUST Co 532.26K sh · $47.10M · Q2 2026
- BCM ADVISORS, LLC 229.49K sh · $20.11M · Q2 2026
- Choate Investment Advisors 207.03K sh · $18.32M · Q2 2026
- COMMON FUND FOR NONPROFIT ORGANIZATIONS 121.01K sh · $10.71M · Q2 2026
- Sound View Wealth Advisors Group, LLC 97.43K sh · $8.62M · Q2 2026
- First Bank & Trust 65.83K sh · $5.97M · Q3 2026
- DAGCO, INC. 65.00K sh · $5.75M · Q2 2026
More on Hirtle & Co., LLC
FAQ
How long has Hirtle & Co., LLC held CATH?
Hirtle & Co., LLC has disclosed CATH holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
What is Hirtle & Co., LLC's current position in CATH?
As of Q2 2026, Hirtle & Co., LLC holds 30.26K shares of CATH (GLOBAL X FDS), valued at $2.68M, representing 0.09% of its reported portfolio and ranking #43.
Has Hirtle & Co., LLC been buying or selling CATH?
In the latest 13F filing (Q2 2026), Hirtle & Co., LLC held unchanged its position in CATH.
Which other funds hold CATH?
Other major institutional holders of CATH include Fund Evaluation Group, LLC, CENTRAL TRUST Co, BCM ADVISORS, LLC, among 33 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.